The US Food and Drug Administration has approved Journavx, also known as suzetrigine 50 milligram oral tablets—a ...
A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.